| Autor: |
D'Amico TA; aDuke Cancer Institute, Durham, North Carolina., Bandini LAM; bNational Comprehensive Cancer Network, Plymouth Meeting, Pennsylvania., Balch A; cThe National Patient Advocate Foundation, Washington, DC., Benson AB; dRobert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois., Edge SB; eRoswell Park Comprehensive Cancer Center, Buffalo, New York., Fitzgerald CL; bNational Comprehensive Cancer Network, Plymouth Meeting, Pennsylvania., Green RJ; fFlatiron Health, New York, New York., Koh WJ; bNational Comprehensive Cancer Network, Plymouth Meeting, Pennsylvania., Kolodziej M; gADVI, Washington, DC., Kumar S; hMayo Clinic Cancer Center, Rochester, Minnesota., Meropol NJ; fFlatiron Health, New York, New York., Mohler JL; eRoswell Park Comprehensive Cancer Center, Buffalo, New York., Pfister D; iMemorial Sloan Kettering Cancer Center, New York, New York; and., Walters RS; jThe University of Texas MD Anderson Cancer Center, Houston, Texas., Carlson RW; bNational Comprehensive Cancer Network, Plymouth Meeting, Pennsylvania. |
| Abstrakt: |
Although oncology care has evolved, outcome assessment remains a key challenge. Outcome measurement requires identification and adoption of a succinct list of metrics indicative of high-quality cancer care for use within and across healthcare systems. NCCN established an advisory committee, the NCCN Quality and Outcomes Committee, consisting of provider experts from NCCN Member Institutions and other stakeholders, including payers and patient advocacy, community oncology, and health information technology representatives, to review the existing quality landscape and identify contemporary, relevant cancer quality and outcomes measures by reevaluating validated measures for endorsement and proposing new measure concepts to fill crucial gaps. This manuscript reports on 22 measures and concepts; 15 that align with existing measures and 7 that are new. |
